A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events

BACKGROUND: Recent evidence highlights the epidemiological value of blood DNA methylation (DNAm) as surrogate biomarker for exposure to risk factors for non-communicable diseases (NCD). DNAm surrogate of exposures predicts diseases and longevity better than self-reported or measured exposures in man...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappozzo, Andrea, McCrory, Cathal, Robinson, Oliver, Freni Sterrantino, Anna, Sacerdote, Carlotta, Krogh, Vittorio, Panico, Salvatore, Tumino, Rosario, Iacoviello, Licia, Ricceri, Fulvio, Sieri, Sabina, Chiodini, Paolo, McKay, Gareth J., McKnight, Amy Jayne, Kee, Frank, Young, Ian S., McGuinness, Bernadette, Crimmins, Eileen M., Arpawong, Thalida Em, Kenny, Rose Anne, O’Halloran, Aisling, Polidoro, Silvia, Solinas, Giuliana, Vineis, Paolo, Ieva, Francesca, Fiorito, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521011/
https://www.ncbi.nlm.nih.gov/pubmed/36175966
http://dx.doi.org/10.1186/s13148-022-01341-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521011/
https://www.ncbi.nlm.nih.gov/pubmed/36175966
http://dx.doi.org/10.1186/s13148-022-01341-4

Ejemplares similares